Better Therapeutics Inc (BTTX)
Better Therapeutics Inc. is a healthcare technology company listed on OTC Markets under the ticker BTTX. As an issuer of common stock, the company is focused on prescription digital therapeutics, including software-based approaches designed around cognitive behavioral therapy for cardiometabolic conditions. Its lead development program, BT-001, is being studied for type 2 diabetes, while other pipeline candidates target diabetes, hypertension, hyperlipidemia, and related liver and kidney disorders. The company also identifies programs such as BT-002, BT-003, and BT-004, which are intended to examine effects on glycemic control, LDL cholesterol, and liver health in patients with cardiometabolic disease. Better Therapeutics was founded in 2015 and is based in San Francisco, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-BTTX
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 13, 2026
|
—
|
—
|
—
|
5.451 K
|
—
|
—
|
—
|
—
|
—
|
—
|
